These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19787813)

  • 1. Hepatitis C drug development at a crossroads.
    Nelson DR
    Hepatology; 2009 Oct; 50(4):997-9. PubMed ID: 19787813
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with Hepatitis C Virus Genotype 1.
    Zimmermann T; Hueppe D; Mauss S; Buggisch P; Pfeiffer-Vornkahl H; Grimm D; Galle PR; Alshuth U
    J Gastrointestin Liver Dis; 2016 Mar; 25(1):15-24. PubMed ID: 27014750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of triple therapy with protease inhibitors in hepatitis C virus genotype 1 naïve patients.
    Nelson DR
    Liver Int; 2011 Jan; 31 Suppl 1():53-7. PubMed ID: 21205138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prompt arrival of antivirals against hepatitis C for HIV patients.
    Barreiro P; Vispo E
    AIDS Rev; 2010; 12(4):242-3. PubMed ID: 21344779
    [No Abstract]   [Full Text] [Related]  

  • 5. New protease inhibitors and direct-acting antivirals for hepatitis C: interferon's long goodbye.
    Dusheiko G; Wedemeyer H
    Gut; 2012 Dec; 61(12):1647-52. PubMed ID: 22936671
    [No Abstract]   [Full Text] [Related]  

  • 6. Protease inhibitors: silver bullets for chronic hepatitis C infection?
    Alkhouri N; Zein NN
    Cleve Clin J Med; 2012 Mar; 79(3):213-22. PubMed ID: 22383557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telaprevir (Incivek) and boceprevir (Victrelis) for chronic hepatitis C.
    Med Lett Drugs Ther; 2011 Jul; 53(1369):57-9. PubMed ID: 21778964
    [No Abstract]   [Full Text] [Related]  

  • 8. The dilemma for patients with chronic hepatitis C: treat now or warehouse?
    Alberti A; Colombo M; Craxì A; Rizzetto M
    Dig Liver Dis; 2014 Jan; 46(1):27-9. PubMed ID: 24268949
    [No Abstract]   [Full Text] [Related]  

  • 9. Decade in review-HCV: hepatitis C therapy-a fast and competitive race.
    Zeuzem S
    Nat Rev Gastroenterol Hepatol; 2014 Nov; 11(11):644-5. PubMed ID: 25223875
    [No Abstract]   [Full Text] [Related]  

  • 10. The results of Phase III clinical trials with telaprevir and boceprevir presented at the Liver Meeting 2010: a new standard of care for hepatitis C virus genotype 1 infection, but with issues still pending.
    Pawlotsky JM
    Gastroenterology; 2011 Mar; 140(3):746-54. PubMed ID: 21255572
    [No Abstract]   [Full Text] [Related]  

  • 11. Triple therapy with first-generation protease inhibitors for patients with genotype 1 chronic hepatitis C: recommendations of the Italian association for the study of the liver (AISF).
    ; Coco B; Caraceni P; Aghemo A; Bitetto D; Bruno R; Ciancio A; Marzioni M; Petta S; Rendina M; Valenti L;
    Dig Liver Dis; 2014 Jan; 46(1):18-24. PubMed ID: 24119482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C in 2012: On the fast track towards IFN-free therapy for hepatitis C?
    Wedemeyer H
    Nat Rev Gastroenterol Hepatol; 2013 Feb; 10(2):76-8. PubMed ID: 23296251
    [No Abstract]   [Full Text] [Related]  

  • 13. Telaprevir phase 3 realize trial starts.
    AIDS Patient Care STDS; 2008 Oct; 22(10):837. PubMed ID: 18847391
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lead-in in triple therapy for hepatitis C virus. Is it necessary or not?].
    Lué A; Simón Marco MÁ
    Gastroenterol Hepatol; 2014; 37(7):408-10. PubMed ID: 24951301
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Telaprevir triple therapy in chronic hepatitis C genotype 1 patients receiving haemodialysis.
    Wiegand J; Maasoumy B; Buggisch P; Buslau A; Schiefke I; Berg T; Wedemeyer H; Sarrazin C; Hinrichsen H
    Aliment Pharmacol Ther; 2014 Jun; 39(11):1342-4. PubMed ID: 24803258
    [No Abstract]   [Full Text] [Related]  

  • 16. Treating hepatitis C in the elderly: the future is near?
    Conti F; Vitale G; Andreone P
    Expert Opin Pharmacother; 2014 Oct; 15(14):2019-28. PubMed ID: 25154694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding telaprevir improves cure rate in patient with HCV infection.
    AIDS Patient Care STDS; 2010 Dec; 24(12):807. PubMed ID: 21188771
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic hepatitis C virus infection in 2013--quo vadis?
    Prelipcean CC; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):7-10. PubMed ID: 24505885
    [No Abstract]   [Full Text] [Related]  

  • 19. The end of the beginning for hepatitis C treatment.
    Dieterich D
    Hepatology; 2012 Mar; 55(3):664-5. PubMed ID: 22174100
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hepatitis C: current status and perspectives].
    Pol S; Corouge M
    Rev Prat; 2014 May; 64(5):605-12. PubMed ID: 24923038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.